L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
7 active ingredients 7 principios activos 7 个活性成分 7 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Axitinib
L01EK01active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Fruquintinib
L01EK04active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Tivozanib
L01EK03active US GB ES EU
active US GB ES EU - Anlotinib
L01EKactive CN
active CN - 甲磺酸阿帕替尼
L01EKactive CN
active CN - 伏罗尼布
L01EKactive CN
active CN - 索凡替尼
L01EKactive CN
active CN
By dosage form, across markets
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).